Literature DB >> 28125313

Effects of early intratympanic steroid injection in patients with acoustic trauma caused by gunshot noise.

Young-Soo Chang1, Kang Hyun Bang1, Byoungseo Jeong1, Gang-Gyu Lee1.   

Abstract

CONCLUSION: This study evaluated the efficacy of concurrent administration of ITSI and systemic steroids in delayed treatment of NIHL after gunshot noise exposure. The results showed additional hearing benefits with administration of ITSI. Further evaluation is warranted to confirm this efficacy.
OBJECTIVE: This investigation evaluated the effects of early administration of an intratympanic steroid injection (ITSI) in combination with systemic steroids treatment in patients with acoustic trauma caused by gunshot noise.
METHODS: Nineteen patients eligible under the criteria established concerning delayed treatment for noise-induced hearing loss (NIHL) were enrolled in this study. Patients were divided into two groups: those who received prednisolone (PD) only (n = 8), and those who received PD with ITSI (n = 11). ITSI treatment was initiated simultaneously alongside systemic PD administration. These patients received ITSI every other day for a total of four treatments. Pure-tone air conduction threshold audiometry, to record the pure-tone average (PTA) at 2, 4, and 8 kHz, was conducted upon each patient's initial visit, and 1 month after starting treatment, to evaluate the degree of hearing gain (hearing gain (dB) = (initial PTA) - (final PTA)).
RESULTS: The initial PTA in PD-only and PD with ITSI groups were 52.75 ± 15.50 dB and 50.27 ± 12.01 dB, respectively. There were no significant differences in the baseline characteristics of the two groups, which include age and the number of days that treatment was delayed. In the multivariable linear regression analysis, both the initial PTA and the treatment method showed a significant association (R2 = 0.41). The unstandardized regression coefficient of the initial PTA was 0.47 (p = 0.02). Patients with additional ITSI showed significant improvement in the degree of hearing gain compared with the PD-only group (unstandardized regression coefficient =11.48, p = 0.03).

Entities:  

Keywords:  Noise induced hearing loss; gunshot noise; hearing gain; intratympanic steroid injection

Mesh:

Substances:

Year:  2017        PMID: 28125313     DOI: 10.1080/00016489.2017.1280850

Source DB:  PubMed          Journal:  Acta Otolaryngol        ISSN: 0001-6489            Impact factor:   1.494


  6 in total

Review 1.  Inner Ear Drug Delivery for Sensorineural Hearing Loss: Current Challenges and Opportunities.

Authors:  Sophie S Liu; Rong Yang
Journal:  Front Neurosci       Date:  2022-05-24       Impact factor: 5.152

Review 2.  Current insights in noise-induced hearing loss: a literature review of the underlying mechanism, pathophysiology, asymmetry, and management options.

Authors:  Trung N Le; Louise V Straatman; Jane Lea; Brian Westerberg
Journal:  J Otolaryngol Head Neck Surg       Date:  2017-05-23

Review 3.  Inner Ear Hair Cell Protection in Mammals against the Noise-Induced Cochlear Damage.

Authors:  Muhammad Waqas; Song Gao; Muhammad Kazim Ali; Yongming Ma; Wenyan Li
Journal:  Neural Plast       Date:  2018-07-15       Impact factor: 3.599

4.  Standard Audiograms for Koreans Derived through Hierarchical Clustering Using Data from the Korean National Health and Nutrition Examination Survey 2009-2012.

Authors:  Young-Soo Chang; Sung Hoon Yoon; Jin Ryoul Kim; Sun-Young Baek; Young Sang Cho; Sung Hwa Hong; Seonwoo Kim; Il Joon Moon
Journal:  Sci Rep       Date:  2019-03-06       Impact factor: 4.379

Review 5.  Prevention of Noise-Induced Hearing Loss Using Investigational Medicines for the Inner Ear: Previous Trial Outcomes Should Inform Future Trial Design.

Authors:  Colleen G Le Prell
Journal:  Antioxid Redox Signal       Date:  2021-10-04       Impact factor: 7.468

6.  Preloaded D-methionine protects from steady state and impulse noise-induced hearing loss and induces long-term cochlear and endogenous antioxidant effects.

Authors:  Kathleen Campbell; Nicole Cosenza; Robert Meech; Michael Buhnerkempe; Jun Qin; Leonard Rybak; Daniel Fox
Journal:  PLoS One       Date:  2021-12-08       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.